API / Intermediate Services

Lifecycle Management

A strong portfolio of more than 170 products (API Product List) for leading therapeutic areas and pipeline of over 20 products at any point of time
IP assessment integral part of product development to facilitate launch of line extensions (combinations, new or reformulation) on product patent expiry
Typical to have a non-infringing synthetic process or novel polymorph
Portfolio of ANDAs either filed or in the pipeline that offer ready-to-use or easily customizable sourcing solutions for prescription to OTC switches
Combination Drug Development: generic API combined with an innovator API in a novel delivery system